share_log

和鉑醫藥-B：截至二零二四年三月三十一日止之股份發行人的證券變動月報表

HBM HOLDINGS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

香港交易所 ·  Apr 8 08:08
Summary by Moomoo AI
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月8日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在本月內無增減，結存總數維持在20,000,000,000股，每股面值0.000025美元，法定/註冊股本總額為500,000美元。此外，公司的股份期權計劃中，首次公開發售後購股權計劃的股份期權數目在本月內無變動，結存數目為39,250,950股。公司亦無行使任何股份期權，因此本月內無新增發行人新股份。報告還提到，公司於2023年6月8日購回了1,750,000股普通股，但本月內普通股的增減總額為零。和鉑醫藥確認，所有證券發行均已獲得董事會正式授權批准，並符合相關法律規定。
和鉑醫藥控股有限公司（和铂医药-B）於2024年4月8日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的公司股份變動情況。報告顯示，公司的法定/註冊股本在本月內無增減，結存總數維持在20,000,000,000股，每股面值0.000025美元，法定/註冊股本總額為500,000美元。此外，公司的股份期權計劃中，首次公開發售後購股權計劃的股份期權數目在本月內無變動，結存數目為39,250,950股。公司亦無行使任何股份期權，因此本月內無新增發行人新股份。報告還提到，公司於2023年6月8日購回了1,750,000股普通股，但本月內普通股的增減總額為零。和鉑醫藥確認，所有證券發行均已獲得董事會正式授權批准，並符合相關法律規定。
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 8 APRIL 2024, REPORTING ON THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 31 MARCH 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding amount of 20,000,000,000 shares, with a face value of $0.000025 per share and a total regulated/registered share capital of $500,000. In addition, the number of share options in the Company's share option plan after the initial public offering was unchanged during the month, with 39,250,950 shares outstanding. The Company also did not exercise any share options, so no new issuer shares were added this month. The report also noted that the company repurchased 1,750,000 shares of ordinary shares on June 8, 2023, but the total increase in ordinary shares during the month was zero. AND PLATINUM PHARMACEUTICALS CONFIRM THAT ALL SECURITIES ISSUANCES HAVE BEEN FORMALLY AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLY WITH RELEVANT LEGAL REQUIREMENTS.
PLATINUM PHARMACEUTICALS HOLDINGS LIMITED (PLATINUM PHARMACEUTICALS-B) FILED ITS LATEST SECURITIES MONTH CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 8 APRIL 2024, REPORTING ON THE CHANGES IN THE COMPANY'S SHARES FOR THE YEAR ENDED 31 MARCH 2024. The report showed that the company's regulated/registered share capital remained unchanged during the month, with a total outstanding amount of 20,000,000,000 shares, with a face value of $0.000025 per share and a total regulated/registered share capital of $500,000. In addition, the number of share options in the Company's share option plan after the initial public offering was unchanged during the month, with 39,250,950 shares outstanding. The Company also did not exercise any share options, so no new issuer shares were added this month. The report also noted that the company repurchased 1,750,000 shares of ordinary shares on June 8, 2023, but the total increase in ordinary shares during the month was zero. AND PLATINUM PHARMACEUTICALS CONFIRM THAT ALL SECURITIES ISSUANCES HAVE BEEN FORMALLY AUTHORIZED BY THE BOARD OF DIRECTORS AND COMPLY WITH RELEVANT LEGAL REQUIREMENTS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more